EUVIMEDEUVIMED entdecken
Crossref

Metastatic Prostate Cancer with Low-Volume Primary Tumors – A National Cancer Database Analysis on Metastasis Profile and Survival Outcomes

Mohamed Javid Raja Iyub, Pushan Prabhakar, Deerush Kannan Sakthivel, Aditi Chandrasekaran, Rohan Garje, Murugesan Manoharan

Clinical Genitourinary Cancer · 2026

DOI: 10.1016/j.clgc.2025.102494 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genitourinary Cancer, 2026. Verfasst von Mohamed Javid Raja Iyub und 5 weiteren Autor:innen. Beteiligte Einrichtung: Miami Cancer Institute, Baptist Health South Florida, Miami, FL. Electronic address: mohamedjavid.rajaiyub@baptisthealth.net. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Adenocarcinoma. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: A tumor confined within the prostate gland is termed localized prostate cancer (PCa). However, metastasis could rarely develop in such low-volume primary tumors. The nature of these metastatic prostate cancers with low-volume primary tumors is largely underexplored. The objective of our study was to analyze the baseline characteristics, metastatic patterns, and survival outcomes of this condition from the National Cancer Database (NCDB). METHODS: Data from patients diagnosed with metastatic prostate cancer with low-volume primary tumors between 2004 and 2021 were analyzed for patient characteristics, metastatic trends, variations by histopathology type, and survival outcomes. Multivariable logistic regression was used to identify various factors associated with this condition. Survival outcomes were evaluated using the Kaplan-Meier analysis. RESULTS: A total of 1,613,004 individuals diagnosed with clinically localized PCa were analyzed. Among them, 45,010 patients had distant metastasis. The most common site of metastasis was bone, followed by lung, liver, and brain. The most common histopathology type was adenocarcinoma (94.3%). The median overall survival (OS) of metastatic prostate cancer with low-volume primary tumors was 37.13 (95% Confidence Interval (CI), 36.57-37.68) months. The best OS in single-site metastasis was seen in lung metastasis (median OS: 54.34 [95% CI, 42.10-66.58] months), and the worst was seen in liver metastasis (median OS: 18.17 [95% CI, 12.70-23.63] months). Adenocarcinoma had a better prognosis (median OS: 38.51 [95% CI, 37.91-39.10] months) than non-adenocarcinoma (median OS: 17.58 [95% CI, 16.40-18.75] months). All results had a P-value less than .001. CONCLUSION: This comprehensive analysis reveals that metastatic prostate cancer with low-volume primary tumors is relatively uncommon (2.8% of ≤ T2 disease), with bone being the most common metastatic site. Isolated metastasis in the lungs and adenocarcinoma had better OS among the metastasis sites and histopathology type, respectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsAdenocarcinomaHumansMaleAgedDatabases, FactualMiddle AgedNeoplasm MetastasisKaplan-Meier EstimatePrognosisBone NeoplasmsAged, 80 and over

Stichwörter der Autor:innen

AdenocarcinomaMetastatic patternPrimary low-volume tumourProstate cancer with metastasisSurvival analysis

Autor:innen und Institutionen

  • Miami Cancer Institute, Baptist Health South Florida, Miami, FL. Electronic address: mohamedjavid.rajaiyub@baptisthealth.net.
  • Miami Cancer Institute, Baptist Health South Florida, Miami, FL.
  • Miami Cancer Institute, Baptist Health South Florida, Miami, FL; Herbert Wertheim College of Medicine, Florida International University, Miami, FL.

Zitieren

APA

Raja Iyub, M. J., Prabhakar, P., Sakthivel, D. K., Chandrasekaran, A., Garje, R., & Manoharan, M. (2026). Metastatic Prostate Cancer with Low-Volume Primary Tumors – A National Cancer Database Analysis on Metastasis Profile and Survival Outcomes. Clinical Genitourinary Cancer. https://doi.org/10.1016/j.clgc.2025.102494

Vancouver

Raja Iyub MJ, Prabhakar P, Sakthivel DK, Chandrasekaran A, Garje R, Manoharan M. Metastatic Prostate Cancer with Low-Volume Primary Tumors – A National Cancer Database Analysis on Metastasis Profile and Survival Outcomes. Clinical Genitourinary Cancer. 2026. doi:10.1016/j.clgc.2025.102494

BibTeX
@article{RajaIyub2026,
  author = {Raja Iyub, Mohamed Javid and Prabhakar, Pushan and Sakthivel, Deerush Kannan and Chandrasekaran, Aditi and Garje, Rohan and Manoharan, Murugesan},
  title = {Metastatic Prostate Cancer with Low-Volume Primary Tumors – A National Cancer Database Analysis on Metastasis Profile and Survival Outcomes},
  journal = {Clinical Genitourinary Cancer},
  year = {2026},
  doi = {10.1016/j.clgc.2025.102494}
}
Kostenlos starten →